This study is for people with Type 1 Diabetes who are overweight or have obesity. Participants will add an investigational once-weekly injection medication or placebo to their current insulin treatment.
The study aims to see how this medication can help with blood sugar control and weight management in individuals with Type 1 Diabetes.
Qualified participants may be compensated for their time and travel.